WS #3062

The most significant signal in this data dump is the potential breakthrough in US-Iran negotiations, corroborated by multiple sources including GDELT and ANSA, which reports a possible deal within 48 hours. This development is driving European stock markets higher (STOXX 600 up 1.5%, Milan up 1.8%) and causing a sharp decline in oil prices (Brent down 6% to under $100, WTI down 5.99% to $86.8) and gas (down over 6%), as it could ease geopolitical tensions in the Strait of Hormuz. This is bearish for energy sectors but bullish for broader indices and sectors like tech, luxury, and autos. Concurrently, Iran's demand for transit fees up to $2 million per ship in the Strait of Hormuz, reported by Bloomberg and GDELT, adds a countervailing risk that could reignite oil volatility if negotiations fail. In corporate developments, several biotech and healthcare companies show strong positive signals: IMUNON reports improved survival in its OVATION 2 trial, Sarepta announces strong early siRNA trial results, and AEON Biopharma receives constructive FDA feedback, all bullish for biotech stocks. Conversely, ProMIS Neurosciences misses Q4 EPS estimates significantly, and DigitalOcean Holdings announces a $700 million share offering, leading to bearish sentiment. In technology, SLB expands its AI partnership with Nvidia, bullish for both companies, while OpenAI's surprise discontinuation of its Sora video generator after five months indicates a strategic shift that could impact AI-related stocks. Other notable signals include Volkswagen's potential pivot to defense production with Israel's Rafael Advanced Defence Systems, as reported by Financial Times, which could affect VW's stock and defense sectors. Additionally, the European Central Bank's statement on readiness to respond to energy shocks, per GDELT, provides stability assurance amid market fluctuations. Pre-market movers across sectors indicate ongoing volatility, with specific tickers like PMN and DOCN showing significant movements.